July 2022

Clinical effectiveness and cost-effectiveness may favor lamotrigine over newer antiseizure treatments levetiracetam and zonisamide for focal epilepsy.
Read More

Discontinuing antidepressant therapy significantly increased the risk of relapse among patients in primary care practices who felt well enough to stop taking antidepressants.
Read More

In patients with Alzheimer’s disease with clinically significant apathy, treatment with methylphenidate for 6 months in ADMET 2 was associated with a modest improvement in apathy.
Read More

Eptinezumab infusion within 1 to 6 hours of migraine onset was associated with significantly faster relief of headache pain and symptoms compared with placebo.
Read More

Researchers found that depression increased the risk of vascular disease and all-cause mortality in patients with multiple sclerosis, according to a recent study.
Read More

Subscribe to Value-Based Care in Neurology

Stay up to date with personalized medicine by subscribing to receive the free VBCN e‑Newsletter.